The cost-utility of a care coordination/home telehealth programme for veterans with diabetes

Journal of Telemedicine and Telecare

Volumn 13, Issue 6, 2007, Pages 318-321

  Barnett, Tracey E ^a   Chumbler, Neale R ^a,b,c   Vogel Bruce, W ^a,c   Beyth, Rebecca J ^a,c   Ryan, Patricia ^d   Figueroa, Sarita ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VA HSR and D Stroke QUERI   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d VISN 8 Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DIABETES MELLITUS; ECONOMICS; HEALTH CARE DELIVERY; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATIENT CARE; QUALITY ADJUSTED LIFE YEAR; RETROSPECTIVE STUDY; VETERAN;

AGED; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; DIABETES MELLITUS; HUMANS; MALE; MIDDLE AGED; PATIENT-CENTERED CARE; QUALITY-ADJUSTED LIFE YEARS; RETROSPECTIVE STUDIES; VETERANS;

EID: 40149087403     PISSN: 1357633X     EISSN: 17581109     Source Type: Journal    
DOI: 10.1258/135763307781644843     Document Type: Article

References (18)

1. Perlin JB, Kolodner RM, Roswell RH. The Veterans Health Administration: quality, value, accountability, and information as transforming strategies for patient-centered care. Am J Manag Care 2004;10:828-36
2. Barnett TE, Chumbler NR, Vogel WB, Beyth RJ, Qin H, Kobb R. The effectiveness of a care coordination home telehealth program for veterans with diabetes mellitus: a 2-year follow-up. Am J Manag Care 2006;12:467-74
3. Chumbler NR, Neugaard B, Kobb R, Ryan P, Qin H, Joo Y. Evaluation of a care coordination/home-telehealth program for veterans with diabetes: health services utilization and health-related quality of life. Eval Health Prof 2005;28:464-78
4. Chumbler NR, Vogel WB, Garel M, Qin H, Kobb R, Ryan P. Health services utilization of a care coordination/home-telehealth program for veterans with diabetes: a matched-cohort study. J Ambul Care Manage 2005;28:230-40
5. Wagner TH, Goldstein MK. Behavioral interventions and cost- effectiveness analysis. Prev Med 2004;39:1208-14
6. Hailey D. The need for cost-effectiveness studies in telemedicine. J Telemed Telecare 2005;11:379-83
7. Kazis LE, Miller DR, Clark JA, et al. Improving the response choices on the veterans SF-36 health survey role functioning scales: results from the Veterans Health Study. J Ambul Care Manage 2004;27:263-80
8. Brazier J, Roberts J, Deverill M. The estimation of a preference- based measure of health from the SF-36. J Health Econ 2002;21:271-92
9. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992;146:473-81
10. Lee SJ, Anasetti C, Kuntz KM, Patten J, Antin JH, Weeks JC. The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia. Blood 1998;92:4047-52
11. Fisher L, Chesla CA, Bartz RJ, et al. The family and type 2 diabetes: a framework for intervention. Diabetes Educ 1998;24:599-607
12. Goodwin JS, Hunt WC, Key CR, Samet JM. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA 1987;258:3125-30
13. Gilmer TP, O'Connor PJ, Manning WG, Rush WA. The cost to health plans of poor glycemic control. Diabetes Care 1997;20:1847-53
14. Gilmer TP, O'Connor PJ, Rush WA, et al. Predictors of health care costs in adults with diabetes. Diabetes Care 2005;28:59-64
15. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34
16. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997;20:614-20
17. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-9
18. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-62